The Role of Calcitonin Gene‐Related Peptide in High‐Altitude Headache: A Prospective Field Study
Annals of Clinical and Translational Neurology · 2026
DOI: 10.1002/acn3.70374 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, 2026. Verfasst von Roman Schniepp und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University Hospital, LMU Munich, Munich, Germany. Hauptthemen laut MEDLINE: Calcitonin Gene-Related Peptide, Tears, Headache, Altitude Sickness. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
High‐altitude headache (HAH) is a common neurological condition associated with rapid ascent to high altitude. The pathophysiological mechanisms underlying HAH remain incompletely understood. Calcitonin gene‐related peptide (CGRP), a neuropeptide implicated in migraine pathophysiology, may play a key role in the pathophysiology of the disorder due to the shared clinical presentation of migraine and HAH. This study investigated tear fluid CGRP concentrations in response to high‐altitude exposure and headache in healthy volunteers.
Methods
A prospective field study was conducted during a high‐altitude trekking expedition in the Alps. Headache and accompanying symptoms were raised using a structured questionnaire, and tear fluid samples were collected at study Day 1 (baseline, 450 m), at study Day 3 (3647 m), and at study Day 4 (4554 m). Tear fluid CGRP concentrations were quantified using a commercial ELISA kit.
Results
Thirteen participants were included in the analysis. At 4554 m, 61.5% of participants reported a HAH. In participants with HAH, increase of tear fluid CGRP was significantly higher compared to participants without HAH (HAH: +1.49 ± 1.74 ng/mL, no HAH: −0.42 ± 0.64 ng/mL; p = 0.011). Increase of tear fluid CGRP levels was significantly higher in participants with a moderate‐to‐severe headache (+1.86 ± 1.86 ng/mL) compared to participants with mild headache (−0.19 ± 0.75 ng/mL; p = 0.008).
Interpretation
The results support a potential role for CGRP in the pathophysiology of HAH. Further studies with a larger number of participants are needed to determine the mechanisms of the disorder.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, University Hospital, LMU Munich, Munich, Germany.
- Institut für Notfallmedizin und Medizinmanagement (INM), University Hospital, LMU Munich, Munich, Germany.
- Department of Anaesthesiology and Intensive Care, Klinikum Garmisch-Partenkirchen, Garmisch-Partenkirchen, Germany.
ORCID-Profile: Katharina Kamm
Zitieren
APA
Schniepp, R., Karrasch, L., Breitenstein, H., Straube, A., & Kamm, K. (2026). The Role of Calcitonin Gene‐Related Peptide in High‐Altitude Headache: A Prospective Field Study. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.70374
Vancouver
Schniepp R, Karrasch L, Breitenstein H, Straube A, Kamm K. The Role of Calcitonin Gene‐Related Peptide in High‐Altitude Headache: A Prospective Field Study. Annals of Clinical and Translational Neurology. 2026. doi:10.1002/acn3.70374
BibTeX
@article{Schniepp2026,
author = {Schniepp, Roman and Karrasch, Ludwig and Breitenstein, Helena and Straube, Andreas and Kamm, Katharina},
title = {The Role of Calcitonin Gene‐Related Peptide in High‐Altitude Headache: A Prospective Field Study},
journal = {Annals of Clinical and Translational Neurology},
year = {2026},
doi = {10.1002/acn3.70374}
}
EUVIMED